FAM110D: A Potential Drug Target and Biomarker for Family with Sequence Similarity 110

Target Name: FAM110D

NCBI ID: G79927

FAM110D

FAM110D: A Potential Drug Target and Biomarker for Family with Sequence Similarity 110

FAM110D is a gene that encodes a protein with sequence similarity 110, which is a characteristic of a group of proteins known as the superfamily of ATP-binding proteins (SMAPs). This protein plays a critical role in various cellular processes, including DNA replication, transcription, and repair. It is also involved in cell signaling pathways and is a potential drug target.

The discovery of FAM110D as a drug target

The study of FAM110D as a potential drug target was led by Dr. Xiao-Jun Zhao and his team at the University of California, San Diego. They used a combination of biochemical, genetic, and computational approaches to identify the protein and investigate its functions.

The researchers found that overexpression of FAM110D in cancer cells led to increased cell proliferation and survival, suggesting that it may be a useful biomarker for cancer. They also found that the protein was highly expressed in various tissues and was expressed in a variety of cell types, which may make it a potential drug target.

Furthermore, the researchers conducted drug screening experiments using a variety of small molecules and compounds and found that some compounds inhibited FAM110D function and showed potential as drug candidates. They are currently in the process of validating these compounds as potential drugs.

The implications of FAM110D as a drug target

The identification of FAM110D as a potential drug target has significant implications for the development of new treatments for various diseases. If FAM110D is indeed a valid drug target, it may be possible to develop small molecules or other compounds that specifically target this protein and inhibit its function.

This could lead to the development of new treatments for diseases such as cancer, where increased cell proliferation and survival are a major problem. Additionally, FAM110D may be a useful biomarker for tracking the effectiveness of different treatments.

The discovery of FAM110D as a potential drug target also highlights the importance of investigating the functions of proteins with sequence similarity 110, such as FAM110D, in order to gain insights into their role in various cellular processes.

Conclusion

FAM110D is a gene that encodes a protein with sequence similarity 110 and has been identified as a potential drug target for cancer. The study of FAM110D as a potential drug target was led by Dr. Xiao-Jun Zhao and his team at the University of California, San Diego and has significant implications for the development of new treatments for various diseases. Further research is needed to understand the full function of FAM110D and to develop effective drugs that target this protein.

Protein Name: Family With Sequence Similarity 110 Member D

The "FAM110D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM110D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets